American Association for Clinical Chemistry
Improving healthcare through laboratory medicine
NACB: Tumor Markers PDF

LMPG: Practice Guidelines And Recommendations For Use Of Tumor Markers In The Clinic
  (Draft Guidelines - Second Posting)

Table of Contents - PDF Document Format
(Right click link to save file to your computer)

Section 1 Foreword and introduction 
Section 2 Quality Requirements: Includes a summary of recommendations of the different sub-committees. 
Section 3 3A: Use of Tumor Markers in Testicular Cancer 
3B: Use of Tumor Markers in Prostate Cancer 
3C: Use of Tumor Markers in Colorectal Cancer
3D: Use of Tumor Markers in Primary Liver Cancer 
3E: Use of Tumor Markers in Ovarian Cancer 
3F: Use of Tumor Markers in Breast Cancer 
3G: Use of Tumor Markers in Gastric Cancer 
3H: Use of Tumor Markers in Bladder Cancer 
3I: Tumor Markers in Pancreatic Ductal Adenocarcinoma 
3J: Use of Tumor Markers in Cervical Cancer 
3K: Use of Tumor Markers in Monoclonal Gammopathies 
3L: Use of Tumor Markers in Malignant Melanoma 
3M: Use of Tumor Markers in Parathyroid Gland Adenomas and Carcinomas 
3N: Use of Tumor Markers in Neoplasms of the Dispersed Neuroendocrine System 
3O: Use of Tumor Markers in Differentiated Epithelial Thyroid Carcinoma
3P: Use of Tumor Markers in Lung Cancer 
Section 4 4A: Use of Microarrays in Cancer Diagnostics
4B: Use of MALDI-TOF Mass Spectometry Profiling to Diagnose Cancer